Business● Low20m ago · Nov 11, 2026, 9:03 PM
Lakefront Biotherapeutics GAAP EPS of €0.20, revenue of €26.1M
GlobeAlert Desk · curated from Seeking Alpha Tech · global
Lakefront Biotherapeutics reported GAAP EPS of €0.20 and revenue of €26.1 million. This is a standard financial update for the company.
GlobeAlert aggregates and classifies open sources; the story above belongs to its publisher. Summaries are machine-generated from the source text. How we score stories.
GlobeAlert context
What the desk knows about this story
Threat level
0 Low
Scored from severity, scale, escalation potential and source agreement. Below the alert threshold.
Sources
1 publisher
Single-source so far. Treat details as unconfirmed until more publishers report.
Category
Business
Not flagged as developing.
More in Business
Business19m agoU.S. equities rebounded with the bond market closedSeeking Alpha TechBusiness19m agoTetra Tech Non-GAAP EPS of $0.49 beats by $0.02, revenue of $1.34B beats by $190MSeeking Alpha TechBusiness21m agoEuro price today in Guatemala: closing quote for November 11Infobae · ArgentinaBusiness23m agoIs it worth investing in companies that are not listed on the Stock Exchange?Folha de S.Paulo · Brazil